Nath Bio-Genes (India)
Nath Bio-Genes (India) Performance
Day Range
- Low 205
- High 210
52 Week Range
- Low 128.85
- High 244.6
- Open Price205.65
- Previous Close207.75
- Volume32697
Start SIP in Nath Bio-Genes (India)
Start SIPNath Bio-Genes (India) Investment Rating
-
Master Rating:
-
Nath Bio Genes India has an operating revenue of Rs. 952.71 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 16% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 134 indicates it belongs to a poor industry group of Agricultural Operations and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock definitely has some strength, you may want to examine it in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 235 | 45 | 25 | 22 | 209 | 27 |
Operating Expenses Qtr Cr | 198 | 41 | 20 | 17 | 175 | 48 |
Operating Profit Qtr Cr | 37 | 4 | 6 | 5 | 34 | -21 |
Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
Interest Qtr Cr | 3 | 2 | 3 | 3 | 3 | 2 |
Tax Qtr Cr | 0 | 0 | 1 | 0 | 0 | 3 |
Net Profit Qtr Cr | 33 | 2 | 1 | 1 | 31 | -116 |
Nath Bio-Genes (India) Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹213.39
- 50 Day
- ₹211.23
- 100 Day
- ₹201.09
- 200 Day
- ₹191.45
- 20 Day
- ₹213.97
- 50 Day
- ₹215.97
- 100 Day
- ₹199.59
- 200 Day
- ₹177.59
Nath Bio-Genes (India) Resistance and Support
Resistance | |
---|---|
First Resistance | ₹210.89 |
Second Resistance | ₹214.02 |
Third Resistance | ₹216.94 |
RSI | 44.37 |
MFI | 64.41 |
MACD Single Line | -0.28 |
MACD | -1.6 |
Support | |
---|---|
First Resistance | ₹204.84 |
Second Resistance | ₹201.92 |
Third Resistance | ₹198.79 |
Nath Bio-Genes (India) Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 42,566 | 2,562,048 | 60.19 |
Week | 59,014 | 3,187,925 | 54.02 |
1 Month | 103,370 | 5,661,583 | 54.77 |
6 Month | 77,517 | 4,087,489 | 52.73 |
Nath Bio-Genes (India) Result Highlights
Nath Bio-Genes (India) Synopsis
NSE-Agricultural Operations
Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 301.29 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2023. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.Market Cap | 390 |
Sales | 327 |
Shares in Float | 1.03 |
No of funds | 12 |
Yield | 0.96 |
Book Value | 0.69 |
U/D Vol ratio | 1.4 |
LTDebt / Equity | |
Alpha | 0.07 |
Beta | 0.97 |
Nath Bio-Genes (India)
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 45.6% | 45.6% | 45.6% | 45.6% |
Mutual Funds | 4.62% | 4.62% | 4.62% | 4.62% |
Foreign Portfolio Investors | 0.07% | 0.13% | 0.15% | 0.01% |
Financial Institutions/ Banks | ||||
Individual Investors | 30.37% | 30.17% | 30.62% | 31.61% |
Others | 19.34% | 19.48% | 19.01% | 18.16% |
Nath Bio-Genes (India) Management
Name | Designation |
---|---|
Mr. Satish Kagliwal | Managing Director |
Mr. Madhukar Deshpande | Director |
Ms. Ashu Jain | Director |
Mrs. Jeevanlata Kagliwal | Director |
Mr. Vadla Nagabhushanam | Director |
Mrs. Sweta Kagliwal | Director |
Mr. Hitesh Purohit | Director |
Nath Bio-Genes (India) Forecast
Price Estimates
Nath Bio-Genes (India) Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-10 | Quarterly Results | |
2023-04-22 | Audited Results & Final Dividend | |
2023-02-14 | Quarterly Results | |
2022-10-20 | Quarterly Results | |
2022-08-13 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Company Name
- CMP
- Chg(%)
- Titan Company
- 3215
- -1.5
- Grasim Inds
- 1931
- -1.4
- Hero Motocorp
- 3006
- -0.9
- St Bk of India
- 590
- -0.8
- B P C L
- 349
- -0.8
Nath Bio-Genes (India) FAQs
What is Share Price of Nath Bio-Genes (India) ?
Nath Bio-Genes (India) share price is ₹205 As on 27 September, 2023 | 16:18
What is the Market Cap of Nath Bio-Genes (India) ?
The Market Cap of Nath Bio-Genes (India) is ₹391.4 Cr As on 27 September, 2023 | 16:18
What is the P/E ratio of Nath Bio-Genes (India) ?
The P/E ratio of Nath Bio-Genes (India) is 10.4 As on 27 September, 2023 | 16:18
What is the PB ratio of Nath Bio-Genes (India) ?
The PB ratio of Nath Bio-Genes (India) is 0.7 As on 27 September, 2023 | 16:18